Category: Regulatory

Introduction The NIH’s decision to cap indirect costs at 15% marks a significant shift in federal research funding policy. Previously, some institutions received up to 69% in indirect cost recovery, funding everything from lab space to research administration. Now, the federal government aims to streamline spending and focus funds on direct research costs. But is… Read more